IMV INC.

IMV
Delayed Quote. Delayed  - 08/13 04:00:00 pm
6.29CAD +6.43%
Prev.5.9100
Open5.8500
High6.3500
Low5.7900
Volume198 847
Latest news
1d ago
1d ago
08/05
08/03
Chart IMV INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance7,947,946,87
Spread/Res.-21%-21%-8,4%
Spread/Supp.8,1%49%63%
Support5,824,223,87
Financials
Sales 2020 1,44 M 1,09 M 1,09 M
Net income 2020 -30,1 M -22,7 M -22,7 M
Net Debt 2020 - - -
P/E ratio 2020 -12,2x
Yield 2020 -
Capitalization 393 M 297 M 297 M
Capi. / Sales 2020 272x
Capi. / Sales 2021 110x
Nbr of Employees 62
Free-Float 99,4%
Company
IMV Inc. is a clinical-stage biopharmaceutical company focused on immunotherapy in oncology. The Company’s drug delivery platform (DPX) enables the programming of immune cells in vivo. The Company’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy combining DPX with a specific...
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-08-12 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 9,15 CAD
Last Close Price 6,29 CAD
Spread / Highest target 74,9%
Spread / Average Target 45,5%
Spread / Lowest Target 1,75%